A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Published:2022-11-15 Issue:Supplement 1 Volume:140 Page:11774-11775
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Avila Ana Maria¹,Arain Saad²,Sweiss Karen³,Patel Pritesh⁴,Houshyar Samin⁵,Calip Gregory S⁶,Khan Irum¹,Rubinstein Paul G.¹,Uzoka Chukwuemeka⁷,Quigley John G.⁴

Affiliation:

1. 1Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL

2. 2Division of Hematology/Oncology, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, IL

3. 3Division of Hematology/Oncology, University of Illinois Cancer Center, Chicago, IL

4. 4Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL

5. 5Division of Internal Medicine, University of Illinois at Chicago, Chicago, IL

6. 6Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL

7. 7Division of Hematology/Oncology, University of Illinois, College of Medicine, Chicago, IL

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP